Cargando…

Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study

OBJECTIVE: To develop a population-specific methodology for estimating glycaemic control that optimises resource allocation for patients with diabetes in rural Sri Lanka. DESIGN: Cross-sectional study. SETTING: Trincomalee, Sri Lanka. PARTICIPANTS: Patients with non-insulin-treated type 2 diabetes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Monica, Hoy, Gregory E., Dugan, Sarah P., McEwen, Laura N., Gunaratnam, Naresh, Wyckoff, Jennifer, Jeevaraaj, Thangarasa, Saththiyaseelan, Arunachalam, Ganeikabahu, B., Katulanda, Prasad, Balis, Ulysses, Herman, William H., Saha, Anjan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371026/
https://www.ncbi.nlm.nih.gov/pubmed/32690534
http://dx.doi.org/10.1136/bmjopen-2020-038148
_version_ 1783561071702835200
author Choo, Monica
Hoy, Gregory E.
Dugan, Sarah P.
McEwen, Laura N.
Gunaratnam, Naresh
Wyckoff, Jennifer
Jeevaraaj, Thangarasa
Saththiyaseelan, Arunachalam
Ganeikabahu, B.
Katulanda, Prasad
Balis, Ulysses
Herman, William H.
Saha, Anjan K.
author_facet Choo, Monica
Hoy, Gregory E.
Dugan, Sarah P.
McEwen, Laura N.
Gunaratnam, Naresh
Wyckoff, Jennifer
Jeevaraaj, Thangarasa
Saththiyaseelan, Arunachalam
Ganeikabahu, B.
Katulanda, Prasad
Balis, Ulysses
Herman, William H.
Saha, Anjan K.
author_sort Choo, Monica
collection PubMed
description OBJECTIVE: To develop a population-specific methodology for estimating glycaemic control that optimises resource allocation for patients with diabetes in rural Sri Lanka. DESIGN: Cross-sectional study. SETTING: Trincomalee, Sri Lanka. PARTICIPANTS: Patients with non-insulin-treated type 2 diabetes (n=220) from three hospitals in Trincomalee, Sri Lanka. OUTCOME MEASURE: Cross-validation was used to build and validate linear regression models to identify predictors of haemoglobin A1c (HbA1c). Validation of models that regress HbA1c on known determinants of glycaemic control was thus the major outcome. These models were then used to devise an algorithm for categorising the patients based on estimated levels of glycaemic control. RESULTS: Time since last oral intake other than water and capillary blood glucose were the statistically significant predictors of HbA1c and thus included in the final models. In order to minimise type II error (misclassifying a high-risk individual as low-risk or moderate-risk), an algorithm for interpreting estimated glycaemic control was created. With this algorithm, 97.2% of the diabetic patients with HbA1c ≥9.0% were correctly identified. CONCLUSIONS: Our calibrated algorithm represents a highly sensitive approach for detecting patients with high-risk diabetes while optimising the allocation of HbA1c testing. Implementation of these methods will optimise the usage of resources devoted to the management of diabetes in Trincomalee, Sri Lanka. Further external validation with diverse patient populations is required before applying our algorithm more widely.
format Online
Article
Text
id pubmed-7371026
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73710262020-07-22 Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study Choo, Monica Hoy, Gregory E. Dugan, Sarah P. McEwen, Laura N. Gunaratnam, Naresh Wyckoff, Jennifer Jeevaraaj, Thangarasa Saththiyaseelan, Arunachalam Ganeikabahu, B. Katulanda, Prasad Balis, Ulysses Herman, William H. Saha, Anjan K. BMJ Open Diabetes and Endocrinology OBJECTIVE: To develop a population-specific methodology for estimating glycaemic control that optimises resource allocation for patients with diabetes in rural Sri Lanka. DESIGN: Cross-sectional study. SETTING: Trincomalee, Sri Lanka. PARTICIPANTS: Patients with non-insulin-treated type 2 diabetes (n=220) from three hospitals in Trincomalee, Sri Lanka. OUTCOME MEASURE: Cross-validation was used to build and validate linear regression models to identify predictors of haemoglobin A1c (HbA1c). Validation of models that regress HbA1c on known determinants of glycaemic control was thus the major outcome. These models were then used to devise an algorithm for categorising the patients based on estimated levels of glycaemic control. RESULTS: Time since last oral intake other than water and capillary blood glucose were the statistically significant predictors of HbA1c and thus included in the final models. In order to minimise type II error (misclassifying a high-risk individual as low-risk or moderate-risk), an algorithm for interpreting estimated glycaemic control was created. With this algorithm, 97.2% of the diabetic patients with HbA1c ≥9.0% were correctly identified. CONCLUSIONS: Our calibrated algorithm represents a highly sensitive approach for detecting patients with high-risk diabetes while optimising the allocation of HbA1c testing. Implementation of these methods will optimise the usage of resources devoted to the management of diabetes in Trincomalee, Sri Lanka. Further external validation with diverse patient populations is required before applying our algorithm more widely. BMJ Publishing Group 2020-07-19 /pmc/articles/PMC7371026/ /pubmed/32690534 http://dx.doi.org/10.1136/bmjopen-2020-038148 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Diabetes and Endocrinology
Choo, Monica
Hoy, Gregory E.
Dugan, Sarah P.
McEwen, Laura N.
Gunaratnam, Naresh
Wyckoff, Jennifer
Jeevaraaj, Thangarasa
Saththiyaseelan, Arunachalam
Ganeikabahu, B.
Katulanda, Prasad
Balis, Ulysses
Herman, William H.
Saha, Anjan K.
Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title_full Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title_fullStr Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title_full_unstemmed Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title_short Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study
title_sort imputing hba1c from capillary blood glucose levels in patients with type 2 diabetes in sri lanka: a cross-sectional study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371026/
https://www.ncbi.nlm.nih.gov/pubmed/32690534
http://dx.doi.org/10.1136/bmjopen-2020-038148
work_keys_str_mv AT choomonica imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT hoygregorye imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT dugansarahp imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT mcewenlauran imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT gunaratnamnaresh imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT wyckoffjennifer imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT jeevaraajthangarasa imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT saththiyaseelanarunachalam imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT ganeikabahub imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT katulandaprasad imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT balisulysses imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT hermanwilliamh imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy
AT sahaanjank imputinghba1cfromcapillarybloodglucoselevelsinpatientswithtype2diabetesinsrilankaacrosssectionalstudy